Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.

Crickard L, Babas T, Seth S, Silvera P, Koriazova L, Crotty S.

PLoS One. 2012;7(11):e48706. doi: 10.1371/journal.pone.0048706. Epub 2012 Nov 2.

PMID:
23133652
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.

He Y, Wang Y, Struble EB, Zhang P, Chowdhury S, Reed JL, Kennedy M, Scott DE, Fisher RW.

Virol J. 2012 Sep 24;9:217. doi: 10.1186/1743-422X-9-217.

PMID:
23006741
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies.

Xu C, Meng X, Yan B, Crotty S, Deng J, Xiang Y.

Virology. 2011 Sep 15;418(1):67-73. doi: 10.1016/j.virol.2011.06.029. Epub 2011 Aug 2.

PMID:
21810533
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.

Zaitseva M, Kapnick SM, Meseda CA, Shotwell E, King LR, Manischewitz J, Scott J, Kodihalli S, Merchlinsky M, Nielsen H, Lantto J, Weir JP, Golding H.

J Virol. 2011 Sep;85(17):9147-58. doi: 10.1128/JVI.00121-11. Epub 2011 Jun 29.

PMID:
21715493
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Smallpox vaccines: targets of protective immunity.

Moss B.

Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Review.

PMID:
21198662
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Capturing the natural diversity of the human antibody response against vaccinia virus.

Lantto J, Haahr Hansen M, Rasmussen SK, Steinaa L, Poulsen TR, Duggan J, Dennis M, Naylor I, Easterbrook L, Bregenholt S, Haurum J, Jensen A.

J Virol. 2011 Feb;85(4):1820-33. doi: 10.1128/JVI.02127-10. Epub 2010 Dec 8.

PMID:
21147924
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Ramasamy S, Liu CQ, Tran H, Gubala A, Gauci P, McAllister J, Vo T.

Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x. Review.

PMID:
20860656
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein.

Shinoda K, Wyatt LS, Moss B.

Virology. 2010 Sep 15;405(1):41-9. doi: 10.1016/j.virol.2010.05.025. Epub 2010 Jun 17.

PMID:
20673745
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

McCausland MM, Benhnia MR, Crickard L, Laudenslager J, Granger SW, Tahara T, Kubo R, Koriazova L, Kato S, Crotty S.

Antivir Ther. 2010;15(4):661-75. doi: 10.3851/IMP1573.

PMID:
20587859
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.

Benhnia MR, McCausland MM, Laudenslager J, Granger SW, Rickert S, Koriazova L, Tahara T, Kubo RT, Kato S, Crotty S.

J Virol. 2009 Dec;83(23):12355-67. doi: 10.1128/JVI.01593-09. Epub 2009 Sep 30.

PMID:
19793826
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.

Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS.

Vaccine. 2009 Mar 4;27(10):1549-56. doi: 10.1016/j.vaccine.2009.01.010. Epub 2009 Jan 23.

PMID:
19168105
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.

Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL.

Vaccine. 2009 Feb 18;27(8):1154-65. doi: 10.1016/j.vaccine.2008.12.035. Epub 2009 Jan 13.

PMID:
19146908
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement.

Benhnia MR, McCausland MM, Moyron J, Laudenslager J, Granger S, Rickert S, Koriazova L, Kubo R, Kato S, Crotty S.

J Virol. 2009 Feb;83(3):1201-15. doi: 10.1128/JVI.01797-08. Epub 2008 Nov 19.

PMID:
19019965
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.

Fogg CN, Americo JL, Earl PL, Resch W, Aldaz-Carroll L, Eisenberg RJ, Cohen GH, Moss B.

J Virol. 2008 Aug;82(16):8022-9. doi: 10.1128/JVI.00568-08. Epub 2008 Jun 4.

PMID:
18524827
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.

Benhnia MR, McCausland MM, Su HP, Singh K, Hoffmann J, Davies DH, Felgner PL, Head S, Sette A, Garboczi DN, Crotty S.

J Virol. 2008 Apr;82(7):3751-68. doi: 10.1128/JVI.02244-07. Epub 2008 Jan 30.

PMID:
18234801
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk